MedTrace Logo

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

NCT05206578 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2022-01-25

No results posted yet for this study

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.

Conditions

  • Primary Hypercholesterolemia

Interventions

DRUG

AGT2, AGZ

Tablet, q.d.

DRUG

AGT2

Tablet, q.d.

DRUG

AGT4, AGZ

Tablet, q.d.

DRUG

AGT4

Tablet, q.d.

Sponsors & Collaborators

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2022-07-07
Completion
2022-09-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05206578 on ClinicalTrials.gov